A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12)

Haematologica

Volumn 89, Issue 2, 2004, Pages 239-241

  Invernizzi, Rosangela ^a,d   Benatti, Chiara ^a   Travaglina, Erica ^a   Girina, Margherita ^a   Bernascani, Paalo ^b   Lani, Carlo ^c   Ascari, Edaarda ^e  

^a Medicina Interna ed Oncolagia Medica   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Ospedale Versilia   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e NONE

Author keywords

8p11; Eosinophilia; Lymphoblastic lymphoma; Myeloproliferative syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PROTEIN TYROSINE KINASE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; LEUKEMIA REMISSION; LYMPHATIC LEUKEMIA; MALE; MYELOPROLIFERATIVE DISORDER; PHYSICAL EXAMINATION; RECIPROCAL CHROMOSOME TRANSLOCATION; RELAPSE; ACUTE DISEASE; CHROMOSOME 13; CHROMOSOME 8; EOSINOPHILIA; GENE TRANSLOCATION; GENETICS; MYELOID LEUKEMIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; TREATMENT FAILURE; ULTRASTRUCTURE;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; EOSINOPHILIA; HUMANS; LEUKEMIA, MYELOID; MALE; MYELOPROLIFERATIVE DISORDERS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; TRANSLOCATION, GENETIC; TREATMENT FAILURE;

EID: 2942612976     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bain BJ. Cytogenetic and molecular genetic aspects of eosinophilic leukaemias. Br J Haematol 2003;122:173-9.
2. Macdonald D, Reiter A, Cross NCP. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002;107:101-7.
3. Abruzzo LV, Jaffe ES, Cotelingam JD, Whang-Peng J, Del Duca V, Medeiros LJ. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 1992;16:236-45.
4. Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood 1995; 85:1881-7.
5. Suzan F, Gulasch G, Terre C, Garcia I, Bastie JN, Maarek O, et al. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13) (p12;q12). Br J Haematol 2003;121:312-4.
6. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet 1998;18:84-7.
7. Popovici C, Zhang B, Grégoire MJ, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood 1999;93:1381-9.
8. Guasch G, Mack GJ, Popovici C, Dastugue N, Birnbaum D, Rattner JB, et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood 2000;95:1788-96.
9. Demiroglu A, Steer EJ, Heath C Taylor K, Bentley M, Allen SL, et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001;98:3778-83.
10. Heath C, Cross NC. Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1. J Biol Chem 2003;12:(Epub ahead of print).